In the spring of 2020, MitoLab and Conservation X Labs collaborated on a handheld, point-of-care COVID test. The device uses an RT-LAMP assay to provide test results in under 30 minutes. Critically, this highly-sensitive test can be administered to patients in the field as it does not require laboratory equipment.
Currently, the device is on track to receive FDA EUA approval in the fall and to manufacture one million tests per month by early 2022. The project team anticipates that the device will be available for $5 per test in 2022.